Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
Baxter
Fish and Richardson
Healthtrust
Covington
McKesson
UBS
Accenture

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019753

« Back to Dashboard

NDA 019753 describes ETHMOZINE, which is a drug marketed by Shire and is included in one NDA. Additional details are available on the ETHMOZINE profile page.

The generic ingredient in ETHMOZINE is moricizine hydrochloride. Additional details are available on the moricizine hydrochloride profile page.
Summary for 019753
Tradename:ETHMOZINE
Applicant:Shire
Ingredient:moricizine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019753

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Jun 19, 1990TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Jun 19, 1990TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Jun 19, 1990TE:RLD:No

Expired US Patents for NDA 019753

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-002 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-001 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-003 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Shire ETHMOZINE moricizine hydrochloride TABLET;ORAL 019753-003 Jun 19, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Farmers Insurance
Harvard Business School
Citi
QuintilesIMS
Fish and Richardson
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.